Profile Details

Create Project

★★★★★

☆☆☆☆☆

USD 90 /hr

★★★★★

☆☆☆☆☆

Hire Dr. Tanya S.

United States

USD 90 /hr

Oncology Research Scientist & Medical Writer | Grant Writing | CAR-T & Cell Therapy | UCLA | PhD

Profile Summary

I am a PhD-trained scientist and medical writer with 6+ years of hands-on oncology research experience at UCLA, specializing in cancer therapeutics, precision medicine, and immunotherapy — including CAR-T, NK, and iNKT-based cell therapies. My work spans the full scientific communication pipeline: from designing hypothesis-driven experiments and conducting in vitro/in vivo assays, to writing peer-reviewed manuscripts, securing competitive grant funding, and translating complex data into clear narratives for diverse audiences. I have served as lead or co-author on 11 peer-reviewed publications, collaborating with clinicians, statisticians, bioinformaticians, and pathologists. I am also proficient in scientific data visualization using BioRender, Adobe Illustrator, and Canva, and have strong familiarity with FDA, EMA, ICH, IRB, and HIPAA compliance frameworks. Whether you need a compelling grant proposal, a publication-ready manuscript, or expert scientific consulting in oncology and cell therapy, I bring both deep domain knowledge and polished communication skills to every project.

Subject Matter Expertise

• ★ Cancer Research
• ☆ Drug Development
• ☆ In vitro Preclinical Toxciology
• ☆ In vivo Preclinical Toxicology
• ☆ In vitro Diagnostics
• ☆ In vitro Diagnostic Validation
• ☆ In vitro Diagnostic Design
• ☆ Women's Health
• ☆ Ovarian Cancer
• ☆ Precision Medicine
• ☆ Immunotherapy
• ☆ Technical & Scientific Writing
• ☆ Manuscript & Journal Article Writing
• ☆ Grant Writing

Services

• Writing
• Research
• Consulting

Writing Clinical Trial Documentation, Medical Writing, Non-Medical Regulatory Writing, Technical Writing, Creative Writing, Newswriting, General Proofreading & Editing

Research Market Research, Meta-Research, Feasibility Study, Fact Checking, Gap Analysis, Gray Literature Search, Scientific and Technical Research

Consulting Healthcare Consulting, Operations Consulting, Scientific and Technical Consulting, Regulatory Consulting

Work Experience

Project Scientist

University of California at Los Angeles

- Present

Project Scientist

UCLA

August 2018 - February 2024

Education

phd in molecular biology

IIT Kharagpur

January 2026 - January 2026

Certifications

• Good Clinical Practice (GCP)

  CITI Program (citiprogram.org) UCLA

  January 2026 - Present

• NIH Grants Writing

  NIH Office of Extramural Research

  October 2025 - Present

• Biomedical Research Ethics

  CITI Program (UCLA)

  June 2021 - Present

• HIPAA Compliance Training

  UCLA

  August 2018 - February 2024

Publications

JOURNAL ARTICLE

Tanya Singh, Yan-Ruide Li, Zhe Li, Yichen Zhu, Miao Li, Yuning Chen, Derek Lee, Christopher J. Ochoa, Gabriella DiBernardo, Wenbin Guo, et al. (2025). Overcoming ovarian cancer resistance and evasion to CAR-T cell therapy by harnessing allogeneic CAR-NKT cells . Med.

Tanya Singh, Sara Huerta-Yepez, Po-Chun Chen, Kawaljit Kaur, Yash Jain, Favour Esedebe, Yi Jou Liao, Gabriella DiBernardo, Neda A Moatamed, Ao Mei, et al. (2025). Supercharged NK cells, unlike primary activated NK cells, effectively target ovarian cancer cells irrespective of MHC-class I expression . BMJ Oncology.

Tanya Singh, Yan-Ruide Li, Christopher J. Ochoa, Yichen Zhu, Adam Kramer, Matthew Wilson, Ying Fang, Yuning Chen, Gabriella Di Bernardo, Enbo Zhu, et al. (2023). Profiling ovarian cancer tumor and microenvironment during disease progression for cell-based immunotherapy design . iScience.

Tanya Singh, Yan-Ruide Li, Christopher J. Ochoa, Yichen Zhu, Adam Kramer, Matthew Wilson, Ying Fang, Yuning Chen, Gabriella Di Bernardo, Enbo Zhu, et al. (2023). Profiling ovarian cancer tumor and microenvironment during disease progression for cell-based immunotherapy design . iScience.

Tanya Singh, Adam Neal, Gabriella Dibernardo, Neela Raheseparian, Neda Moatamed, Sanaz Memarzadeh (2022). Efficacy of birinapant in combination with carboplatin in targeting platinum‑resistant epithelial ovarian cancers . International Journal of Oncology.

Tanya Singh, Adam Neal, Tiffany Lai, Neela Rahseparian, Tristan Grogan, David Elashoff, Peter Scott, Matteo Pellegrini, Sanaz Memarzadeh (2021). Combining ReACp53 with Carboplatin to Target High-Grade Serous Ovarian Cancers . Cancers.

Tanya Singh, Adam S. Neal, Neda A. Moatamed, Sanaz Memarzadeh (2020). Exploring the Potential of Drug Response Assays for Precision Medicine in Ovarian Cancer . International Journal of Molecular Sciences.

Tanya Singh, Angshuman Ray Chowdhuri, Sudip Kumar Ghosh, Sumanta Kumar Sahu (2016). Carbon Dots Embedded Magnetic Nanoparticles @Chitosan @Metal Organic Framework as a Nanoprobe for pH Sensitive Targeted Anticancer Drug Delivery . ACS Applied Materials & Interfaces.